Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis.

Journal of Clinical Microbiology
Louis Y A ChaiRaoul Herbrecht

Abstract

The monitoring and prediction of treatment responses to invasive aspergillosis (IA) are difficult. We determined whether serum galactomannan index (GMI) trends early in the course of disease may be useful in predicting eventual clinical outcomes. For the subjects recruited into the multicenter Global Aspergillosis Study, serial GMIs were measured at baseline and at weeks 1, 2, and 4 following antifungal treatment. Clinical response and survival at 12 weeks were the outcome measures. GMI trends were analyzed by using the generalized estimation equation approach. GMI cutoffs were evaluated by using receiver-operating curve analyses incorporating pre- and posttest probabilities. Of the 202 study patients diagnosed with IA, 71 (35.1%) had a baseline GMI of ≥ 0.5. Week 1 GMI was significantly lower for the eventual responders to treatment at week 12 than for the nonresponders (GMIs of 0.62 ± 0.12 and 1.15 ± 0.22, respectively; P = 0.035). A GMI reduction of >35% between baseline and week 1 predicted a probability of a satisfactory clinical response. For IA patients with pretreatment GMIs of <0.5 (n = 131; 64.9%), GMI ought to remain low during treatment, and a rising absolute GMI to >0.5 at week 2 despite antifungal treatment herald...Continue Reading

References

Jun 26, 2001·The Western Journal of Medicine·R GilbertE J Elliott
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·François BoutboulPatricia Ribaud
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Jun 3, 2004·The Lancet Infectious Diseases·Monique A S H Mennink-KerstenPaul E Verweij
Jan 18, 2005·Clinical Microbiology Reviews·Nina Singh, David L Paterson
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan MaertensJohan Van Eldere
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher D PfeifferNasia Safdar
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan A MaertensPaul E Verweij
Jun 29, 2007·The Pediatric Infectious Disease Journal·William J SteinbachBarbara D Alexander
Jan 15, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L J Wheat, T J Walsh
Jan 30, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O PenackE Thiel
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marisa H MiceliElias Anaissie
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A Marr
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Aug 16, 2008·The Pediatric Infectious Disease Journal·Randall HaydenThomas J Walsh
Oct 10, 2008·The Cochrane Database of Systematic Reviews·Mariska M LeeflangChristina M Vandenbroucke-Grauls
Jan 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D NeofytosK Marr
Jan 22, 2010·Critical Reviews in Microbiology·Michael A Pfaller, Daniel J Diekema
Feb 12, 2010·Journal of Clinical Microbiology·Sophia KooFrancisco M Marty
Aug 19, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Simone A NouérElias Anaissie

❮ Previous
Next ❯

Citations

Jun 14, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cynthia E FisherTobias M Hohl
Feb 22, 2016·Infectious Disease Clinics of North America·Margaret V Powers-Fletcher, Kimberly E Hanson
May 13, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·F S de FontbruneA Alanio
Sep 21, 2013·Expert Opinion on Pharmacotherapy·Richard H DrewJohn R Perfect
Jul 2, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas F PattersonJohn E Bennett
Nov 24, 2016·The Journal of Antimicrobial Chemotherapy·Johan A MaertensPatricia Muñoz
Jul 31, 2013·American Journal of Clinical Pathology·Pablo A MoncadaNiaz Banaei
Dec 3, 2016·Therapeutic Advances in Hematology·Markus Ruhnke, Stefan Schwartz
Jan 20, 2019·Journal of Fungi·Thomas F Patterson, J Peter Donnelly
Jan 15, 2019·Current Opinion in Infectious Diseases·José-Artur Paiva, José M Pereira
Jul 30, 2019·Journal of Medical Microbiology·Komal M RavalKishore Paknikar
Nov 12, 2014·Expert Review of Anti-infective Therapy·Małgorzata MikulskaClaudio Viscoli
Dec 24, 2017·Infectious Diseases and Therapy·Matteo BassettiAntonio Vena
Jul 7, 2017·Current Fungal Infection Reports·Adilia Warris, Thomas Lehrnbecher
May 5, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Laura L KovandaWilliam W Hope
Apr 11, 2018·Frontiers in Microbiology·Thomas LehrnbecherKonrad Bochennek
Jul 9, 2020·Infectious Diseases and Therapy·Alessandro RussoFrancesco Menichetti
Mar 5, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·François DanionUNKNOWN Collaborators
Nov 2, 2019·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L PangL Y A Chai
Jan 20, 2015·Annals of Internal Medicine·Kieren A MarrJohan A Maertens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.